Molecular Pathology

With recent innovations in molecular pathology, we’re now able to reduce some of the trial and error in medicine and identify some predispositions before disease is present. LifeBrite Labs’ molecular pathology testing applies the science of molecular genetic testing for enhanced precision medicine and innovative patient care. With an understanding of each patient’s genetic profile, you can optimize drug treatments and better assess future health risks. You can also more precisely diagnose STIs and vaginal infections. Get the analysis you need to act earlier and with greater precision, for the best in individualized patient care. If you’d like to learn more about our offerings in this exciting, emerging field, please give us a call. Learn more about LifeBrite Laboratories’:

Genetic Information Nondiscrimination Act of 2008

The Genetic Information Nondiscrimination Act of 2008 (GINA) makes it illegal for health insurers to request or use one’s genetic information to deny health insurance, or to alter how much one pays for health insurance. It prevents the use of your genetic information to determine if a condition is considered pre-existing. Furthermore, GINA protects individuals from genetic discrimination by employers. GINA does not apply to life, long-term care, or disability insurance. Because of this, residents of some states may be asked to disclose their genetic information. Different states have extended protection to cover other forms of insurance. More information about GINA can be found on GINAhelp.org  or through your state insurance commissioner’s office.